Blackbaud Insider Receives 3,670-Share Equity Award at $0 Cost
Rhea-AI Filing Summary
Blackbaud, Inc. (BLKB) – Form 4 filing: Director Yogesh K. Gupta received a restricted stock award of 3,670 common shares on 08/01/2025 at an acquisition price of $0.
Footnote 1 states that the award will vest on 08/01/2026, or sooner if Gupta’s board term ends immediately before the company’s 2026 annual director election, provided he is still serving as a director at that time. Following the grant, Gupta’s direct beneficial ownership rose to 12,266 shares. No derivative securities transactions were reported and no open-market purchases or sales occurred.
- Transaction classified as “A” (acquired) and reported under Section 16.
- Form filed by a single reporting person; no amendments noted.
- Equity grant represents routine director compensation and does not involve cash outlay by the insider.
Positive
- Director equity ownership increases, modestly enhancing alignment with shareholder interests.
Negative
- No open-market purchase signal; transaction is part of routine board compensation and provides limited insight into insider sentiment.
Insights
TL;DR: Routine director equity grant; immaterial to valuation but modestly aligns board incentives with shareholders.
The filing discloses a standard annual restricted-stock grant of 3,670 shares to director Yogesh K. Gupta. Because the award was issued at $0 cost and vests after one year (or earlier under board-service conditions), it does not reflect insider sentiment through open-market buying or selling. The post-grant holding of 12,266 shares remains negligible relative to Blackbaud’s total share count, so market impact is minimal. Nonetheless, incremental ownership slightly strengthens incentive alignment, a mild governance positive. From a trading perspective, the event is not material to earnings, cash flow, or capital structure.
FAQ
How many Blackbaud (BLKB) shares did the director acquire?
What is the cost basis of the shares granted to the director?
When will the restricted stock award vest?
What is the director’s total beneficial ownership after the transaction?
Were any derivative securities involved in this Form 4 filing?